From: Early application of CVVH In the complex treatment of patients with early severe acute pancreatitis
Variable | First group | Second group | Third group |
---|---|---|---|
Age | 42 ± 15 | 39 ± 13 | 47 ± 16 |
BMI | 31 ± 5 | 29 ± 4 | 29 ± 5 |
APACHE II score | 17 (5) | 17 (9) | 15 (7) |
SOFA score | 5 (4) | 5 (3) | 5 (3) |
Ranson score | 8 (6) | 8 (7) | 10 (9) |
Early mortality (%) | 27 | 10* | 42 |
Infection (%) | 47 | 35 | 29 |
Overall mortality (%) | 49 | 25* | 51 |